Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.6200
0.00 (0.00%)
At close: Apr 7, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 42.18 million as of April 8, 2026. Its market cap has increased by 14.23% in one year.
Market Cap
42.18M
Enterprise Value
24.82M
Revenue
19.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.62
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 42.18M, a decrease of -82.09%. That is a compound annual growth rate of -31.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 42.18M | -4.75% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QBNK Holding AB | 65.33M |
| Aerowash AB | 60.82M |
| Kontigo Care AB | 55.52M |
| Redsense Medical AB | 48.84M |
| Touchtech AB | 42.01M |
| Gomero Group AB | 36.46M |
| EcoRub AB | 35.71M |
| Vidhance AB | 34.34M |